Cargando…

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus

INTRODUCTION: The aim of the present study was to determine the effect of sitagliptin on microalbuminuria in patients with type 2 diabetes mellitus. MATERIALS AND METHODS: A total of 85 patients with type 2 diabetes mellitus (age >20 years, <80 years, hemoglobin A1c [HbA1c] <8.4%) were rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Hiroko, Okada, Yosuke, Arao, Tadashi, Tanaka, Yoshiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley-Blackwell 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020336/ https://www.ncbi.nlm.nih.gov/pubmed/24843780 http://dx.doi.org/10.1111/jdi.12142

Ejemplares similares

Efficacy of α‐glucosidase inhibitors combined with dipeptidyl‐peptidase‐4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring
por: Kurozumi, Akira, et al.
Publicado: (2013)

Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus
por: Kurozumi, Akira, et al.
Publicado: (2016)

A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control
por: Arao, Tadashi, et al.
Publicado: (2023)

The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
por: Mori, Hiroko, et al.
Publicado: (2017)

Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
por: Kurozumi, Akira, et al.
Publicado: (2017)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
por: Tanaka, Kenichi, et al.
Publicado: (2017)

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2013)

Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2013)

Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
por: Shigematsu, Erina, et al.
Publicado: (2014)

Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes
por: Tanaka, Kenichi, et al.
Publicado: (2020)

A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis
por: Mori, Hiroko, et al.
Publicado: (2019)

Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2014)

Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring
por: Hajime, Maiko, et al.
Publicado: (2017)

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2019)

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012)

Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus
por: Goshima, Yukiko, et al.
Publicado: (2020)

Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2-Day In-Hospital Diabetes Educational Program: The Joetsu Diabetes Prevention Trial
por: Kawahara, Tetsuya, et al.
Publicado: (2008)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015)

Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
por: Zeng, De-kang, et al.
Publicado: (2019)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Miller, Shannon A, et al.
Publicado: (2009)

Diabetes Mellitus and Albuminuria
Publicado: (1882)

Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report
por: Kurozumi, Akira, et al.
Publicado: (2016)

Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels
por: Torimoto, Keiichi, et al.
Publicado: (2017)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Urinary Angiopoietin-2 Is Associated with Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Chen, Shan, et al.
Publicado: (2015)

Correlation of Albuminuria and Diabetic Retinopathy in Type-II Diabetes Mellitus Patients
por: Dash, Shovna, et al.
Publicado: (2022)

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
por: Hajime, Maiko, et al.
Publicado: (2019)

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
por: Engel, Samuel S, et al.
Publicado: (2013)

Ten-year follow-up of sitagliptin treatment in patients with type 2 diabetes mellitus
por: Hattori, Sachiko
Publicado: (2021)

Chitosan oligosaccharide improves the therapeutic efficacy of sitagliptin for the therapy of Chinese elderly patients with type 2 diabetes mellitus
por: Zhao, Lijie, et al.
Publicado: (2017)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria
por: Pan, Qingrong, et al.
Publicado: (2018)

Factors influencing inter‐day glycemic variability in diabetic outpatients receiving insulin therapy
por: Mori, Hiroko, et al.
Publicado: (2016)

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
por: Fukuda, Masahiro, et al.
Publicado: (2018)

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wang, Qiu, et al.
Publicado: (2021)

Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus
por: Asare-Anane, Henry, et al.
Publicado: (2016)

Albuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes Mellitus
por: Miyake, Hitomi, et al.
Publicado: (2018)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
por: Ballav, Chitrabhanu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lvprui064ujhaejaqg7ba52qaq